CTX213
DEAD

Serial Number

99582999

Owner

CRISPR Therapeutics AG

Attorney

Tiffany D. Gehrke

Filing Date

Jan 7, 2026

Add to watchlist:

No watchlists yet
View on USPTO

CTX213 Trademark

Serial Number: 99582999

CTX213 is a trademark filed by CRISPR Therapeutics AG on January 7, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

CRISPR Therapeutics AG (50 trademarks)

ZUG V8 6300 , CH

Entity Type: 99

Trademark Details

Filing Date

January 7, 2026

Registration Date

Not Registered

Goods & Services

Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development

Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of diabetes; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of diabetes

Filing History

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 27, 2026 NWOS
ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
Mar 13, 2026 MAB1
ABANDONMENT - EXPRESS MAILED
Mar 13, 2026 ABN1
TEAS EXPRESS ABANDONMENT RECEIVED
Mar 12, 2026 EXAR
APPLICATION FILING RECEIPT MAILED
Jan 7, 2026 MAFR
NEW APPLICATION ENTERED
Jan 7, 2026 NWAP